AgeX Therapeutics, Inc. (AGE)

SG&A Expenses

$11.60M

TTM · Period ending: · USD

AGE logo

AGE SG&A Expenses

Latest reported$11.60M
AGE SG&A Expenses ($3.87M → $11.60M)
High-resolution chart · PNG

AGE sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
10,997,000
9,624,000
9,328,000
5,971,000
6,708,000
7,403,000
8,139,000
5,647,000
3,869,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.